Symbols / VMD Stock $9.66 +1.79% Viemed Healthcare, Inc.

Healthcare • Medical Devices • United States • NCM
VMD (Stock) Chart
O: — H: — L: — C: — V: —
SMA 20: — SMA 50: — SMA 200: —
Stock Fundamentals
Scroll to Statements
Index EQUITY
Sector Healthcare
Industry Medical Devices
CEO Mr. Casey Hoyt
Exch · Country NCM · United States
Market Cap 371.75M
Enterprise Value 377.32M
Income 14.93M
Sales 270.28M
FCF (ttm) 15.72M
Book/sh 3.72
Cash/sh 0.35
Employees 1,382
Insider 10d —
IPO Aug 09, 2019
Div forward ($/yr)
Div TTM ($/yr)
Dividend Yield
Ex-Div Date
5Y Avg Yield
Yield vs 5Y Avg
Payout 0.00%
P/E 26.11
Forward P/E 24.15
PEG —
P/S 1.38
P/B 2.59
P/C —
EV/EBITDA 7.48
EV/Sales 1.40
Quick Ratio 0.96
Current Ratio 1.18
Debt/Eq 11.11
LT Debt/Eq —
EPS (ttm) 0.37
EPS next Y 0.40
EPS Growth 29.80%
Revenue Growth 25.50%
EPS Gr Q/Q 30.70%
Rev Gr Q/Q —
Earnings (next) 2026-05-05
Earnings (prior) 2026-03-04
ROA 7.25%
ROE 11.11%
ROIC —
Gross Margin 57.52%
Oper. Margin 11.53%
Profit Margin 5.53%
Shs Outstand 38.48M
Shs Float 30.56M
Insider Own 13.85%
Instit Own 67.31%
Short Float 1.06%
Short Ratio 1.07
Short Interest 351.50K
52W High 10.06
vs 52W High -3.98%
52W Low 5.93
vs 52W Low 62.90%
Beta 1.16
Impl. Vol. 40.81%
Rel Volume 0.46
Avg Volume 276.57K
Volume 126.22K
Target (mean) $13.00
Tgt Median $13.00
Tgt Low $11.00
Tgt High $15.00
# Analysts 2
Recom None
Prev Close $9.49
Price $9.66
Change 1.79%
About

Viemed Healthcare, Inc., through its subsidiaries, provides home medical equipment (HME) and post-acute respiratory healthcare services in the United States. The company provides respiratory disease management solutions, including treatment of chronic obstructive pulmonary disease (COPD), which include non-invasive ventilation, percussion vests, and other therapies; and invasive and non-invasive ventilation and related equipment and supplies to patients suffering from COPD. It also sells and rents HME devices, such as non-invasive and invasive ventilators, positive airway pressure (PAP) machines, durable medical equipment, percussion vests, oxygen concentrators, and other medical equipment. In addition, the company provides neuromuscular care and oxygen therapy services; and sleep apnea management which provides sleep solutions and/or equipment, such as PAP, automatic continuous positive airway pressure, and bi-level positive airway pressure machines. Further, it offers in-home sleep apnea testing services; and breast pumps and related lactation equipment and supplies, including fulfillment and support services, as well as healthcare staffing and recruitment services. Viemed Healthcare, Inc. was founded in 2006 and is headquartered in Lafayette, Louisiana.

Valuation Models

Price estimates from analyst targets and simple models.

1. Analyst consensus
$13.00
Mean price target
2. Current target
$9.66
Latest analyst target
3. DCF / Fair value
$7.35
Simplified: (Free Cash Flow ÷ Shares) × 18 (P/FCF multiple). Not a …
Ratings
Current target
$9.66
Low
$11.00
High
$15.00
Mean
$13.00

Latest analyst rating changes

Date Action Analyst Rating Change Price Target
2021-11-03 main RBC Capital — → Outperform $9
2021-03-05 init RBC Capital — → Outperform $13
News
RSS: Latest VMD news
Insider Transactions
Filed Date Insider Relationship Transaction Shares Price Value SEC
2026-03-20 MOORE MICHAEL President — 136,802 $8.77 $1,237,976
2026-01-29 MOORE MICHAEL President — 35,789 — —
2026-01-29 CAMBRE JEROME RICHARD II Officer — 11,492 — —
2026-01-29 FITZGERALD TRAE PAUL Chief Financial Officer — 13,059 — —
2026-01-29 ZEHNDER WILLIAM TODD Chief Operating Officer — 35,790 — —
2026-01-29 HOYT CASEY Chief Executive Officer — 53,060 — —
2026-01-29 FRAZIER WILLIAM Officer and Director — 3,112 — —
2026-01-29 TRAHAN JEREMY LANE General Counsel — 14,365 — —
2026-01-21 MOORE MICHAEL President — 42,768 — —
2026-01-21 CAMBRE JEROME RICHARD II Officer — 14,649 — —
Financials
Statement View
Amounts in millions (2 decimals, no suffix) • EPS per share (2 decimals) • Trend = period evolution • YoY Growth = previous period %
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Total Revenue
270.28
+20.52%
224.26
+22.54%
183.01
+31.82%
138.83
Operating Revenue
270.28
+20.52%
224.26
+22.54%
183.01
+31.82%
138.83
Cost Of Revenue
114.82
+26.10%
91.05
+29.66%
70.22
+29.68%
54.15
Reconciled Cost Of Revenue
87.69
+30.56%
67.17
+35.00%
49.75
+25.85%
39.53
Gross Profit
155.46
+16.71%
133.20
+18.11%
112.78
+33.19%
84.68
Operating Expense
134.75
+14.96%
117.21
+19.83%
97.81
+28.56%
76.08
Research And Development
3.02
-1.66%
3.07
+10.28%
2.78
+3.19%
2.70
Selling General And Administration
130.50
+16.01%
112.48
+20.00%
93.73
+27.77%
73.36
General And Administrative Expense
130.50
+16.01%
112.48
+20.00%
93.73
+27.77%
73.36
Salaries And Wages
9.13
+45.30%
6.29
+7.45%
5.85
+12.44%
5.20
Other Gand A
121.37
+14.28%
106.20
+20.84%
87.88
+28.94%
68.16
Other Operating Expenses
-0.25
-245.66%
0.17
+276.53%
-0.10
+90.09%
-0.99
Total Expenses
249.57
+19.83%
208.26
+23.94%
168.03
+29.02%
130.23
Operating Income
20.71
+29.48%
15.99
+6.81%
14.97
+74.17%
8.60
Total Operating Income As Reported
22.95
+28.21%
17.90
+24.91%
14.33
+73.65%
8.25
EBITDA
51.56
+21.86%
42.31
+15.37%
36.68
+47.79%
24.82
Normalized EBITDA
49.32
+19.24%
41.36
+12.29%
36.84
+46.39%
25.16
Reconciled Depreciation
28.61
+12.79%
25.37
+16.04%
21.86
+39.87%
15.63
EBIT
22.95
+35.42%
16.95
+14.38%
14.81
+61.26%
9.19
Total Unusual Items
2.24
+135.44%
0.95
+694.38%
-0.16
+53.76%
-0.35
Total Unusual Items Excluding Goodwill
2.24
+135.44%
0.95
+694.38%
-0.16
+53.76%
-0.35
Special Income Charges
2.24
+17.53%
1.91
+395.35%
-0.65
-86.42%
-0.35
Net Income
14.93
+32.57%
11.27
+9.98%
10.24
+64.63%
6.22
Pretax Income
21.77
+34.61%
16.17
+12.36%
14.39
+60.08%
8.99
Net Non Operating Interest Income Expense
-1.18
-52.32%
-0.78
-83.02%
-0.42
-115.23%
-0.20
Interest Expense Non Operating
1.18
+52.32%
0.78
+83.02%
0.42
+115.23%
0.20
Net Interest Income
-1.18
-52.32%
-0.78
-83.02%
-0.42
-115.23%
-0.20
Interest Expense
1.18
+52.32%
0.78
+83.02%
0.42
+115.23%
0.20
Other Income Expense
2.24
+135.44%
0.95
+694.38%
-0.16
-127.16%
0.59
Gain On Sale Of Security
—
-0.95
-296.70%
0.48
—
Tax Provision
6.39
+34.24%
4.76
+14.78%
4.15
+49.86%
2.77
Tax Rate For Calcs
0.00
+0.00%
0.00
+2.08%
0.00
-6.49%
0.00
Tax Effect Of Unusual Items
0.66
+135.44%
0.28
+706.76%
-0.05
+56.76%
-0.11
Net Income Including Noncontrolling Interests
15.38
+34.77%
11.41
+11.38%
10.24
+64.63%
6.22
Net Income From Continuing Operation Net Minority Interest
14.93
+32.57%
11.27
+9.98%
10.24
+64.63%
6.22
Net Income From Continuing And Discontinued Operation
14.93
+32.57%
11.27
+9.98%
10.24
+64.63%
6.22
Net Income Continuous Operations
15.38
+34.77%
11.41
+11.38%
10.24
+64.63%
6.22
Minority Interests
-0.44
-206.94%
-0.14
0.00
0.00
Normalized Income
13.35
+26.05%
10.59
+2.29%
10.36
+60.29%
6.46
Net Income Common Stockholders
14.93
+32.57%
11.27
+9.98%
10.24
+64.63%
6.22
Diluted EPS
—
0.28
+12.00%
0.25
+56.25%
0.16
Basic EPS
—
0.29
+7.41%
0.27
+68.75%
0.16
Basic Average Shares
—
38.75
+1.05%
38.35
-0.78%
38.66
Diluted Average Shares
—
40.81
+1.06%
40.38
+1.44%
39.81
Diluted NI Availto Com Stockholders
14.93
+32.57%
11.27
+9.98%
10.24
+64.63%
6.22
Depreciation Amortization Depletion Income Statement
1.49
+0.13%
1.48
+6.61%
1.39
+37.45%
1.01
Depreciation And Amortization In Income Statement
1.49
+0.13%
1.48
+6.61%
1.39
+37.45%
1.01
Depreciation Income Statement
—
—
—
1.01
Earnings From Equity Interest
—
-0.95
-296.70%
0.48
-48.13%
0.94
Gain On Sale Of PPE
2.24
+17.53%
1.91
+395.35%
-0.65
-86.42%
-0.35
Total Other Finance Cost
—
—
—
—
Line Item Trend 2023-12-31
Total Assets
154.90
Current Assets
38.37
Cash Cash Equivalents And Short Term Investments
12.84
Cash And Cash Equivalents
12.84
Cash Equivalents
5.66
Cash Financial
7.18
Receivables
18.45
Accounts Receivable
18.45
Gross Accounts Receivable
29.55
Allowance For Doubtful Accounts Receivable
-11.10
Taxes Receivable
0.00
Inventory
4.63
Prepaid Assets
—
Other Current Assets
2.45
Total Non Current Assets
116.53
Net PPE
76.85
Gross PPE
129.79
Accumulated Depreciation
-52.94
Properties
0.00
Land And Improvements
2.57
Buildings And Improvements
7.95
Machinery Furniture Equipment
4.73
Other Properties
114.19
Leases
0.34
Goodwill And Other Intangible Assets
30.33
Goodwill
29.77
Other Intangible Assets
0.57
Investments And Advances
3.90
Long Term Equity Investment
—
Non Current Deferred Assets
4.56
Non Current Deferred Taxes Assets
4.56
Other Non Current Assets
0.89
Total Liabilities Net Minority Interest
41.00
Current Liabilities
32.12
Payables And Accrued Expenses
19.99
Payables
17.49
Accounts Payable
7.41
Other Payable
7.92
Current Accrued Expenses
2.50
Pensionand Other Post Retirement Benefit Plans Current
2.06
Total Tax Payable
2.15
Income Tax Payable
2.15
Current Debt And Capital Lease Obligation
2.01
Current Debt
1.07
Other Current Borrowings
1.07
Current Capital Lease Obligation
0.93
Current Deferred Liabilities
6.21
Current Deferred Revenue
6.21
Other Current Liabilities
1.87
Total Non Current Liabilities Net Minority Interest
8.88
Long Term Debt And Capital Lease Obligation
8.32
Long Term Debt
6.00
Long Term Capital Lease Obligation
2.32
Stockholders Equity
113.89
Common Stock Equity
113.89
Capital Stock
18.70
Common Stock
18.70
Share Issued
38.51
Ordinary Shares Number
38.51
Treasury Shares Number
0.00
Additional Paid In Capital
15.70
Retained Earnings
79.50
Gains Losses Not Affecting Retained Earnings
—
Minority Interest
0.00
Total Equity Gross Minority Interest
113.89
Total Capitalization
119.90
Working Capital
6.24
Invested Capital
120.97
Total Debt
10.32
Capital Lease Obligations
3.25
Net Tangible Assets
83.56
Tangible Book Value
83.56
Available For Sale Securities
3.90
Inventories Adjustments Allowances
—
Investmentin Financial Assets
3.90
Non Current Accrued Expenses
0.56
Other Inventories
—
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Operating Cash Flow
51.92
+32.81%
39.09
-13.54%
45.21
+62.94%
27.75
Cash Flow From Continuing Operating Activities
51.92
+32.81%
39.09
-13.54%
45.21
+62.94%
27.75
Net Income From Continuing Operations
15.38
+34.77%
11.41
+11.38%
10.24
+64.63%
6.22
Depreciation Amortization Depletion
28.61
+12.79%
25.37
+16.04%
21.86
+39.87%
15.63
Depreciation
28.61
+12.79%
25.37
+16.04%
21.86
+39.87%
15.63
Depreciation And Amortization
28.61
+12.79%
25.37
+16.04%
21.86
+39.87%
15.63
Other Non Cash Items
0.23
-85.11%
1.53
+799.09%
-0.22
—
Stock Based Compensation
9.13
+45.30%
6.29
+7.45%
5.85
+12.44%
5.20
Provisionand Write Offof Assets
—
0.00
0.00
+100.00%
-1.42
Deferred Tax
3.11
+180.96%
-3.84
-166.85%
-1.44
-182.42%
1.75
Deferred Income Tax
3.11
+180.96%
-3.84
-166.85%
-1.44
-182.42%
1.75
Operating Gains Losses
-2.24
-3.37%
-2.17
-1453.75%
0.16
+127.16%
-0.59
Gain Loss On Sale Of PPE
-2.24
-17.53%
-1.91
-395.35%
0.65
+86.42%
0.35
Change In Working Capital
-2.30
-748.73%
0.35
-95.43%
7.78
+6370.97%
-0.12
Change In Receivables
1.16
+119.07%
-6.07
-474.01%
-1.06
+58.61%
-2.56
Changes In Account Receivables
1.16
+119.07%
-6.07
-474.01%
-1.06
+58.61%
-2.56
Change In Inventory
0.06
-89.72%
0.57
+221.61%
-0.47
-256.81%
0.30
Change In Prepaid Assets
-0.50
-192.46%
0.54
-75.00%
2.18
+176.67%
-2.84
Change In Payables And Accrued Expense
0.73
-77.18%
3.22
-21.56%
4.10
+83.77%
2.23
Change In Accrued Expense
0.26
-91.07%
2.86
-42.39%
4.96
+94.55%
2.55
Change In Payable
0.48
+33.43%
0.36
+141.79%
-0.86
-170.13%
-0.32
Change In Account Payable
0.48
+33.43%
0.36
+141.79%
-0.86
-170.13%
-0.32
Change In Other Working Capital
-3.75
-279.13%
2.09
-30.89%
3.03
+10.66%
2.74
Investing Cash Flow
-50.17
-63.41%
-30.70
+41.09%
-52.11
-117.35%
-23.98
Cash Flow From Continuing Investing Activities
-50.17
-63.41%
-30.70
+41.09%
-52.11
-117.35%
-23.98
Net PPE Purchase And Sale
-23.83
+13.17%
-27.45
-16.78%
-23.50
-7.65%
-21.84
Purchase Of PPE
-39.98
-5.86%
-37.77
-44.76%
-26.09
-13.95%
-22.90
Sale Of PPE
16.15
+56.49%
10.32
+298.80%
2.59
+143.46%
1.06
Capital Expenditure
-39.98
-5.86%
-37.77
-44.76%
-26.09
-13.95%
-22.90
Net Investment Purchase And Sale
0.00
-100.00%
0.75
0.00
+100.00%
-2.00
Purchase Of Investment
—
0.00
+100.00%
-0.02
+99.00%
-2.00
Sale Of Investment
0.00
-100.00%
0.75
0.00
0.00
Net Business Purchase And Sale
-26.33
-558.46%
-4.00
+86.02%
-28.61
-20189.36%
-0.14
Purchase Of Business
-26.33
-558.46%
-4.00
+86.02%
-28.61
-20189.36%
-0.14
Financing Cash Flow
-5.79
-56.93%
-3.69
-230.54%
2.83
+118.51%
-15.27
Cash Flow From Continuing Financing Activities
-5.79
-56.93%
-3.69
-230.54%
2.83
+118.51%
-15.27
Net Issuance Payments Of Debt
8.22
+341.13%
-3.41
-261.03%
2.12
+136.26%
-5.84
Issuance Of Debt
22.00
+633.33%
3.00
-76.92%
13.00
0.00
Repayment Of Debt
-13.78
-115.01%
-6.41
+41.11%
-10.88
-86.42%
-5.84
Long Term Debt Issuance
22.00
+633.33%
3.00
-76.92%
13.00
0.00
Long Term Debt Payments
-13.78
-115.01%
-6.41
+41.11%
-10.88
-86.42%
-5.84
Net Long Term Debt Issuance
8.22
+341.13%
-3.41
-261.03%
2.12
+136.26%
-5.84
Short Term Debt Issuance
—
—
8.00
0.00
Short Term Debt Payments
—
—
-7.00
0.00
Net Short Term Debt Issuance
—
—
0.99
0.00
Net Common Stock Issuance
-14.96
-1299.35%
-1.07
-79.97%
-0.59
+93.88%
-9.71
Common Stock Payments
-14.96
-1299.35%
-1.07
-79.97%
-0.59
+93.88%
-9.71
Repurchase Of Capital Stock
-14.96
-1299.35%
-1.07
-79.97%
-0.59
+93.88%
-9.71
Proceeds From Stock Option Exercised
1.44
+41.49%
1.02
-21.95%
1.30
+360.42%
0.28
Net Other Financing Charges
-0.49
-114.47%
-0.23
—
—
Changes In Cash
-4.04
-185.92%
4.70
+215.36%
-4.08
+64.55%
-11.49
Beginning Cash Position
17.54
+36.62%
12.84
-24.09%
16.91
-40.46%
28.41
End Cash Position
13.50
-23.03%
17.54
+36.62%
12.84
-24.09%
16.91
Free Cash Flow
11.93
+805.24%
1.32
-93.11%
19.12
+294.21%
4.85
Interest Paid Supplemental Data
0.87
-8.00%
0.95
+11.63%
0.85
+268.40%
0.23
Income Tax Paid Supplemental Data
7.39
+8.25%
6.83
+91.45%
3.57
—
Dividend Received CFO
0.00
-100.00%
0.15
-85.00%
0.98
-9.18%
1.08
Earnings Losses From Equity Investments
0.00
+100.00%
-0.26
+46.19%
-0.48
+48.13%
-0.94
SEC Filings

Recent 10-K, 10-Q, 8-K, and Form 4 (insider) filings.

Trades
Date User Broker Pattern Type Position Size Entry Price Trade P&L Status
Posts
Published Title Author Category